Fenofibrate attenuates doxorubicin-induced cardiac dysfunction in mice via activating the eNOS/EPC pathway
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fenofibrate attenuates doxorubicin-induced cardiac dysfunction in mice via activating the eNOS/EPC pathway
Authors
Keywords
-
Journal
Scientific Reports
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-13
DOI
10.1038/s41598-021-80984-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of gemfibrozil on cardiotoxicity induced by doxorubicin in male experimental rats
- (2018) Habib Haybar et al. BIOMEDICINE & PHARMACOTHERAPY
- Endothelin-1-Induced Cell Hypertrophy in Cardiomyocytes is Improved by Fenofibrate: Possible Roles of Adiponectin
- (2017) Hsu-Lung Jen et al. Journal of Atherosclerosis and Thrombosis
- Cardiac Remodeling: Concepts, Clinical Impact, Pathophysiological Mechanisms and Pharmacologic Treatment
- (2016) Paula S. Azevedo et al. Arquivos Brasileiros de Cardiologia
- Fenofibrate treatment of rats with experimental autoimmune myocarditis by alleviating Treg/Th17 disorder
- (2016) Huilei Cheng et al. Central European Journal of Immunology
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2016) Piotr Ponikowski et al. EUROPEAN JOURNAL OF HEART FAILURE
- Peroxisome Proliferator-Activated ReceptorαReduces Endothelin-1-Caused Cardiomyocyte Hypertrophy by Inhibiting Nuclear Factor-κB and Adiponectin
- (2016) Hsu-Lung Jen et al. MEDIATORS OF INFLAMMATION
- Protection against doxorubicin-induced myocardial dysfunction in mice by cardiac-specific expression of carboxyl terminus of hsp70-interacting protein
- (2016) Lei Wang et al. Scientific Reports
- PPARα Association With Sirt1 Suppresses Cardiac Fatty Acid Metabolism in the Failing Heart
- (2015) Shin-ichi Oka et al. Circulation-Heart Failure
- In Vivo Protective Effects of Diosgenin against Doxorubicin-Induced Cardiotoxicity
- (2015) Chih-Tai Chen et al. Nutrients
- Allogeneic Mesenchymal Stem Cells Restore Endothelial Function in Heart Failure by Stimulating Endothelial Progenitor Cells
- (2015) Courtney Premer et al. EBioMedicine
- Hormone therapy with tamoxifen reduces plasma levels of NT-B-type natriuretic peptide but does not change ventricular ejection fraction after chemotherapy in women with breast cancer
- (2014) F.B. Silva et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: Design of the RENEW study
- (2013) Thomas J. Povsic et al. AMERICAN HEART JOURNAL
- Cardioprotective effects of fish omega-3 fatty acids on doxorubicin-induced cardiotoxicity in rats
- (2013) R Uygur et al. HUMAN & EXPERIMENTAL TOXICOLOGY
- Peroxisome Proliferator-Activated Receptor Targets for the Treatment of Metabolic Diseases
- (2013) Francisco A. Monsalve et al. MEDIATORS OF INFLAMMATION
- Statins and fibrates do not affect development of spontaneous cartilage damage in STR/Ort mice
- (2013) W. Wei et al. OSTEOARTHRITIS AND CARTILAGE
- Isorhamnetin Protects against Doxorubicin-Induced Cardiotoxicity In Vivo and In Vitro
- (2013) Jing Sun et al. PLoS One
- Far infra-red therapy promotes ischemia-induced angiogenesis in diabetic mice and restores high glucose-suppressed endothelial progenitor cell functions
- (2012) Po-Hsun Huang et al. Cardiovascular Diabetology
- Fenofibrate Improves Vascular Endothelial Function by Reducing Oxidative Stress While Increasing Endothelial Nitric Oxide Synthase in Healthy Normolipidemic Older Adults
- (2012) Ashley E. Walker et al. HYPERTENSION
- Effects of Doxorubicin and Fenofibrate on the Activities of NADH Oxidase and Citrate Synthase in Mice
- (2011) Chun-Xia Yao et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Intramyocardial, Autologous CD34+ Cell Therapy for Refractory Angina
- (2011) Douglas W. Losordo et al. CIRCULATION RESEARCH
- Adiponectin Ameliorates Doxorubicin-induced Cardiotoxicity through Akt Protein-dependent Mechanism
- (2011) Sonomi Maruyama et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Fenofibrate promotes ischemia-induced revascularization through the adiponectin-dependent pathway
- (2010) Ping Li et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Nrf-2 mediated heme oxygenase-1 expression, an antioxidant-independent mechanism, contributes to anti-atherogenesis and vascular protective effects of Ginkgo biloba extract
- (2010) Jia-Shiong Chen et al. ATHEROSCLEROSIS
- The bone marrow–cardiac axis: role of endothelial progenitor cells in heart failure☆
- (2010) Simon Maltais et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- Pleiotropic actions of fenofibrate on the heart
- (2010) Pitchai Balakumar et al. PHARMACOLOGICAL RESEARCH
- Resveratrol treatment protects against doxorubicin-induced cardiotoxicity by alleviating oxidative damage
- (2009) Elif Tatlidede et al. FREE RADICAL RESEARCH
- Acute Exercise Protects Against Doxorubicin Cardiotoxicity
- (2008) Karen Y. Wonders et al. INTEGRATIVE CANCER THERAPIES
- Increased Activities of Cardiac Matrix Metalloproteinases Matrix Metalloproteinase (MMP)–2 and MMP‐9 Are Associated with Mortality during the Acute Phase of ExperimentalTrypanosoma cruziInfection
- (2008) Fredy Roberto Salazar Gutierrez et al. JOURNAL OF INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now